The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 1-13B MPN: Clinical (1)

Fri. Oct 12, 2018 10:10 AM - 11:10 AM No.13 (Osaka International Convention Center, 11F 1101-2)

Chair: Junko Ohyashiki (Department of Adveanced Callular Therapy, Tokyo Medical University, Japan)

[OS1-13B-3] TET2 mutation is a poor prognostic factor for survival in BCR-ABL-negative MPN patients

Yasuhiro Taniguchi1, Hirokazu Tanaka1, Ryosuke Fujiwara1, Yasuyoshi Morita1, Hitoshi Hanamoto2, Yoichi Tatsumi1, Takashi Ashida1, Itaru Matsumura1 (1.Hematol. and Rheumatol., Kindai Univ, Osaka, Japan, 2.Kindai Univ. Nara Hospital, Nara, Japan)

Abstract password authentication.
Password is written on a program and abstract book.

Password